These findings indicate that RP105 may serve as a novel therapeutic target for preventing and treating sepsis-associated AKI by modulating immune cell infiltration, oxidative stress, and ferroptosis, particularly through the regulation of the HO-1/SLC7A11/GPX4 axis. The gene discussed is GPX4; the disease is Sepsis.